Product
rBV A/B
1 clinical trial
1 indication
Indication
BotulismClinical trial
Tolerability and Immunogenicity of a Single 40-µg Dose of Recombinant Botulinum Vaccine A/B (rBV A/B) for the Production of BabyBIG® in Volunteers With Existing Botulinum ImmunityStatus: Not yet recruiting, Estimated PCD: 2025-09-01